ORIGINAL RESEARCH article
Front. Oncol., 20 July 2020
Sec. Gastrointestinal Cancers
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.01044
RETRACTED: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
- CL
Chen Luo 1,2,3†
- XZ
Xiaojian Zhu 1,2,3†
- QL
Qilin Luo 1
- FB
Fanqin Bu 1,2,3
- CH
Chao Huang 1,2,3
- JZ
Jingfeng Zhu 1,2,3
- JZ
Jiefeng Zhao 1,2,3
- WZ
Wenjun Zhang 1,2,3
- KL
Kang Lin 1,2,3
- CH
Cegui Hu 2,3
- ZZ
Zeng Zong 1,3
- HL
Hongliang Luo 1,3
- JH
Jun Huang 1
- ZZ
Zhengming Zhu 1*
1. Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
2. Department of Clinical Medical, Jiangxi Medical College of Nanchang University, Nanchang, China
3. Jiangxi Province Key Laboratory of Molecular Medicine, Nanchang, China
Summary
Citation
Luo C, Zhu X, Luo Q, Bu F, Huang C, Zhu J, Zhao J, Zhang W, Lin K, Hu C, Zong Z, Luo H, Huang J and Zhu Z (2020) RETRACTED: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling. Front. Oncol. 10:1044. doi: 10.3389/fonc.2020.01044
Received
13 April 2020
Accepted
26 May 2020
Published
20 July 2020
Volume
10 - 2020
Edited by
Wen Wen Xu, Jinan University, China
Reviewed by
Yoshinori Katakura, Kyushu University, Japan; Yang Liu, China Medical University, China
Updates
This article was submitted to Gastrointestinal Cancers, a section of the journal Frontiers in Oncology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.